For press inquiries click here to contact us.
Inscripta
Inscripta CEO on Genomic Engineering (Podcast)
Inscripta
Inscripta Eyes Broader Genome Editing Reach with $150M Series E
Genomics PLC
Oxford’s Genomics Pushing the Boundaries of Personalized Medicine
SomaLogic
Proteomics company SomaLogic to chase $1.2B public valuation through SPAC deal
Inscripta
Inscripta closes $150M VC round, scores first commercial buyer of CRISPR gene editing platform
Inscripta
Having shipped its first benchtop gene editing devices, Inscripta draws another $150M from deep investor well
Lyell Immunopharma
Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility
Crossover Health, Inc.
Crossover Health banks $168M Series D
Genomics PLC
Oxford’s Genomics Pushing the Boundaries of Personalized Medicine
Please see important disclaimers in the Terms section.
